2022 Life Sciences Tech Trends - The Metaverse Continuum for Biopharma R&D
The Lens: Life Sciences Reinvention in Focus
Release Date: 11/11/2022
Looking Ahead: Balancing Innovation with Human Insights
The Lens: Life Sciences Reinvention in Focus
Matt Studney, from Merck’s Research Laboratories Information Technology discusses AI's growing role in pharma and the need for responsible implementation to enhance health outcomes.
info_outline
Augmenting Cell & Gene Therapy with Digital Solutions
The Lens: Life Sciences Reinvention in Focus
Explore how Genentech’s digital cell and gene therapy innovation scales life-saving treatments. From virtual journeys to secure supply chains, learn about the tech and collaborations bringing new therapies safely to patients worldwide.
info_outline
Driving Digital in Biopharma Podcast Reinvented
The Lens: Life Sciences Reinvention in Focus
Just like the life sciences industry, the Driving Digital in Biopharma series has evolved. In each episode, we'll explore the way the industry is being reimagined and reinvented. If you're passionate about the future of medicines and medical technologies, improving patient outcomes and pushing the limits of innovation, The Lens is your essential listen.
info_outline
Tech + AI & Data = Innovative medicine for patients
The Lens: Life Sciences Reinvention in Focus
In this insightful episode of Driving Digital in Biopharma, host Tom Lehmann explores with Áine Hanly, Chief Technology Officer at Vir Biotechnology, the transformative role of data and technology in drug development and manufacturing. Áine delves into the advancements in data accessibility and automation, such as single-cell manipulation and high throughput processes, which have notably shortened cycle times and boosted efficiency. She also discusses the innovative use of the Vir AI tool Daisy for antibody design and optimization, which speeds up the process and enhances manufacturability....
info_outline
Inflection Point: Transforming Today’s Labs for the Future
The Lens: Life Sciences Reinvention in Focus
This episode of Driving Digital in Biopharma offers a peek into the digital revolution brewing in the biopharma labs, courtesy of Richard Milne, the Vice-president and general manager of Digital Science Solutions at Thermo Fisher Scientific. From e-commerce roots to pioneering digital science, Richard and Tom delve into the vision for laboratories, and the integration of artificial intelligence and automation in scientific research and lab operations. Their conversation highlights the critical role of digital strategies in enhancing productivity and accelerating scientific advancements....
info_outline
Unlocking Growth: How Digital Innovation is Transforming Commercial Manufacturing
The Lens: Life Sciences Reinvention in Focus
In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares his insights on Vertex's strategic evolution and its commitment to serial innovation through substantial investments in R&D. They discuss the company’s modality-agnostic approach, which allows flexibility in tackling various diseases, as well as covering the strategic use of contract development and manufacturing...
info_outline
Innovating Oncology Patient Experience with Data, Digital & Tech
The Lens: Life Sciences Reinvention in Focus
In this episode of the Driving Digital in Biopharma podcast, Samer Ansari, Head of Data, Digital, and Technology at Takeda Oncology, joins Tom Lehmann, Global Head of Accenture Life Sciences R&D, to discuss the role of digital in creating exceptional HCP and patient experiences. Through their shared passion for data and tech and the importance of using it to positively change not only the Life Sciences industry but also the lives of our loved ones, Samer and Tom explore how Takeda is leveraging data to create a meaningful impact on patients’ experiences. We glimpse into the actions Samer...
info_outline
A modern balancing act: Harmonizing digital, data and traditional ways of working
The Lens: Life Sciences Reinvention in Focus
In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, speaks to Chris Braithwaite, Global Head of Drug Development, Digital and IT Novartis. Achieving digital transformation requires a delicate balance between traditional methods, rapidly emerging technology, and human decision-making. Chris encourages a shift in perspective and a focus on change management, emphasizing that working in a human+machine mode does not entail eliminating human roles. Instead, it involves developing comfort and knowledge regarding data and technology to enhance human potential and increase...
info_outline
Design for the future and deliver progress over perfection
The Lens: Life Sciences Reinvention in Focus
In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, talks with Michel Rider, VP Digital, Analytics and Performance at GSK. Michel reflects on their multi-year quest to modernize digital, data, and analytics capabilities across Development – sharing insights for achieving near-term wins while planning for the future. There is a sense of urgency for patients seeking better, faster treatments. And this is a non-linear endeavor – iteration and evolution are a given. A compressed transformation approach combined with agile experimentation can deliver tangible benefits...
info_outline
Rethink it: Digital is not a thing, digital is a means
The Lens: Life Sciences Reinvention in Focus
In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Jason Bronfeld, Head of Product Development IT at Bristol-Myers Squibb, about the industry re-perceiving itself and capitalizing on the power of digital. When it comes to evolving ways of operating to an ever-better model for the future, a mindset shift is essential – digital is a means and not the end. The biopharma industry is viewed as knowledge-generating enterprises, and while ever-growing amounts of data present complex challenges, a strong digital core will fuel competitive advantages.
info_outlineIn this episode, Tom Lehmann talks with Accenture’s Ross Wooddisse, Managing Director and Life Sciences R&D Lead in Europe, about the 2022 Life Sciences Technology Vision and what the Metaverse continuum means for Biopharma R&D. They discuss how science turns into medicine, a new generation of digital trial capabilities and the fundamental opportunity for the industry to move from disease management towards risk prediction and disease prevention.